EMLA for dental anaesthesia during upper teeth extraction.

The clinical efficacy of EMLA as a topical anesthetic agent instead of palatal injection during maxillary dental extractions: Randomized Control Open label trial - EMLA for palatal anaesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017140

Enrollment

100

Registered

2019-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: EMLA cream: Group B: Participants receiving single stat dose of EMLA application on palatal tissues with 2% Lignocaine hydrochloride injection with 1:80000 adrenaline only on buccal/la

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants indicated for maxillary extraction 2. No signs of local inflammation and infection

Exclusion criteria

Exclusion criteria: • Individuals with uncontrolled chronic systemic diseases, • Individuals with known allergy to agents used

Design outcomes

Primary

Measure	Time frame
Pain - Absence of pain during palatal gingival tissue elevation and during the procedure n. â?¢ No additional palatal injection required Timepoint: 0 - at time of procedure after anaesthesia	—

Secondary

Measure	Time frame
Overall experience. Any side effectsTimepoint: Overall experience during extraction will be evaluated with 5 point Lickertsâ??s scale. Any side effects noted during or after the procedure would also be documented.	—

Countries

India

Contacts

Public ContactAnkita chugh

AIIMS , JODHPUR.

ankitamody@gmail.com08003996891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026